| Cervical Cancer |
| 5472- | AF, | Auranofin induces apoptosis and necrosis in HeLa cells via oxidative stress and glutathione depletion |
| - | in-vitro, | Cerv, | HeLa |
| 5432- | AG, | Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies |
| - | Review, | Cerv, | NA |
| 1907- | AgNPs, | GoldNP, | Cu, | In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Colon, | HCT15 | - | in-vitro, | Cerv, | HeLa |
| 4554- | AgNPs, | Involvement of telomerase activity inhibition and telomere dysfunction in silver nanoparticles anticancer effects |
| - | in-vitro, | Cerv, | HeLa |
| 4393- | AgNPs, | Nanotoxic Effects of Silver Nanoparticles on Normal HEK-293 Cells in Comparison to Cancerous HeLa Cell Line |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | HEK293 |
| 4403- | AgNPs, | Silver Nanoparticles Decorated UiO-66-NH2 Metal-Organic Framework for Combination Therapy in Cancer Treatment |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | GL26 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | CRC, | RKO |
| 4388- | AgNPs, | Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells |
| - | in-vitro, | Cerv, | NA |
| 4422- | AgNPs, | Bioengineering of Piper longum L. extract mediated silver nanoparticles and their potential biomedical applications |
| - | in-vitro, | Cerv, | HeLa |
| 4421- | AgNPs, | Effect of Biologically Synthesized Silver Nanoparticles on Human Cancer Cells |
| - | in-vitro, | Cerv, | NA |
| 4439- | AgNPs, | Anticancer Potential of Green Synthesized Silver Nanoparticles Using Extract of Nepeta deflersiana against Human Cervical Cancer Cells (HeLA) |
| - | in-vitro, | Cerv, | HeLa |
| 4372- | AgNPs, | Negligible particle-specific toxicity mechanism of silver nanoparticles: the role of Ag+ ion release in the cytosol |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Lung, | A549 |
| 326- | AgNPs, | TSA, | Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles |
| - | in-vitro, | Cerv, | HeLa |
| 324- | AgNPs, | CPT, | Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells |
| - | in-vitro, | Cerv, | HeLa |
| 312- | AgNPs, | wortm, | Inhibition of autophagy enhances the anticancer activity of silver nanoparticles |
| - | vitro+vivo, | Cerv, | HeLa |
| 394- | AgNPs, | Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction |
| - | in-vitro, | Cerv, | HeLa |
| 2836- | AgNPs, | Gluc, | Glucose capped silver nanoparticles induce cell cycle arrest in HeLa cells |
| - | in-vitro, | Cerv, | HeLa |
| 5343- | Ajoene, | The garlic compound ajoene covalently binds vimentin, disrupts the vimentin network and exerts anti-metastatic activity in cancer cells |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | BC, | MDA-MB-231 |
| 3435- | aLinA, | Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell lines |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Cerv, | SiHa | - | in-vitro, | Cerv, | C33A |
| 421- | Api, | Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α |
| - | vitro+vivo, | Cerv, | HeLa |
| 2635- | Api, | CUR, | Synergistic Effect of Apigenin and Curcumin on Apoptosis, Paraptosis and Autophagy-related Cell Death in HeLa Cells |
| - | in-vitro, | Cerv, | HeLa |
| 2578- | ART/DHA, | RES, | Synergic effects of artemisinin and resveratrol in cancer cells |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Cerv, | HeLa |
| 562- | ART/DHA, | Artesunate exerts an anti-immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression |
| - | in-vivo, | Cerv, | HeLa |
| 5175- | Ash, | Withaferin A Induces Proteasome Inhibition, Endoplasmic Reticulum Stress, the Heat Shock Response and Acquisition of Thermotolerance |
| - | in-vitro, | Cerv, | CCL-102 |
| 2337- | BBR, | Berberine Inhibited the Proliferation of Cancer Cells by Suppressing the Activity of Tumor Pyruvate Kinase M2 |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Cerv, | HeLa |
| 5592- | BetA, | Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Cerv, | HeLa |
| 5586- | BetA, | Suppression of HIF-1α accumulation by betulinic acid through proteasome activation in hypoxic cervical cancer |
| - | in-vitro, | Cerv, | HeLa |
| 5585- | BetA, | Betulinic acid-induced mitochondria-dependent cell death is counterbalanced by an autophagic salvage response |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | lymphoma, | U937 |
| 2721- | BetA, | Proteomic Investigation into Betulinic Acid-Induced Apoptosis of Human Cervical Cancer HeLa Cells |
| - | in-vitro, | Cerv, | HeLa |
| 2720- | BetA, | Betulinic acid induces apoptosis of HeLa cells via ROS-dependent ER stress and autophagy in vitro and in vivo |
| - | in-vitro, | Cerv, | HeLa |
| 2726- | BetA, | Betulinic acid induces DNA damage and apoptosis in SiHa cells |
| - | in-vitro, | Cerv, | SiHa |
| 2753- | BetA, | Betulinic acid induces apoptosis by regulating PI3K/Akt signaling and mitochondrial pathways in human cervical cancer cells |
| - | in-vitro, | Cerv, | HeLa |
| 5684- | BML, | Bromelain mediates apoptosis in HeLa cells via ROS-independent pathway |
| - | in-vitro, | Cerv, | HeLa |
| 713- | Bor, | Effects of dietary boron on cervical cytopathology and on micronucleus frequency in exfoliated buccal cells |
| - | Analysis, | Cerv, | NA |
| 8971- | BRice, | Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression |
| - | in-vitro, | adrenal, | SK-HEP-1 | - | in-vitro, | SCC, | SCC4 | - | in-vitro, | Liver, | HUH7 | - | in-vitro, | Cerv, | HeLa |
| 6545- | BSB, | The antineoplastic agent α-bisabolol promotes cell death by inducing pores in mitochondria and lysosomes |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | AML, | Jurkat |
| 7978- | BUL, | Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Lung, | A549 | - | in-vitro, | Liver, | HepG2 |
| 7969- | BUL, | Bullatacin triggered ABCB1-overexpressing cell apoptosis via the mitochondrial-dependent pathway |
| - | in-vitro, | Cerv, | KBv200 |
| 7972- | BUL, | Mode of action of bullatacin, a potent antitumor acetogenin: inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes |
| - | vitro+vivo, | Cerv, | HeLa | - | vitro+vivo, | AML, | HL-60 |
| 1207- | CA, | PacT, | Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of α-tubulin acetylation |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Cerv, | HeLa |
| - | in-vitro, | Cerv, | SiHa |
| 5959- | CEL, | Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-κB as a possible target |
| - | in-vitro, | Cerv, | HeLa |
| 7165- | CHA, | The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase |
| - | in-vitro, | Cerv, | HeLa |
| 4479- | Chit, | Chitosan nanoparticles triggered the induction of ROS-mediated cytoprotective autophagy in cancer cells |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | HCC, | SMMC-7721 cell |
| 6069- | CHL, | PDT, | Anti-Cancer Effect of Chlorophyllin-Assisted Photodynamic Therapy to Induce Apoptosis through Oxidative Stress on Human Cervical Cancer |
| - | in-vitro, | Cerv, | HeLa |
| 1145- | CHr, | Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways |
| - | in-vitro, | Cerv, | HeLa |
| 6302- | Cro, | Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases |
| - | Review, | Cerv, | HeLa |
| 6292- | Cro, | Crocetin induces cytotoxicity and enhances vincristine-induced cancer cell death via p53-dependent and -independent mechanisms |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Lung, | A549 | - | in-vitro, | Ovarian, | SKOV3 |
| 945- | Cro, | Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Cerv, | HeLa |
| 478- | CUR, | Curcumin decreases epithelial‑mesenchymal transition by a Pirin‑dependent mechanism in cervical cancer cells |
| - | in-vitro, | Cerv, | SiHa |
| 477- | CUR, | Curcumin induces G2/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells |
| - | in-vitro, | Cerv, | SiHa |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid